ICP	immune checkpoint
mAb	monoclonal antibody
CTLA-4	cytotoxic T lymphocyte associated protein-4
PD-1	programmed deat-1
TIL	tumor-infiltrating lymphocyte
irAEs	immune-related adverse events
LAG-3	lymphocyte activating gene-3
TME	tumor microenvironment
IHC	immunohistochemistry
Ig	immunoglobulin
MHC-II	major histocompatibility complex
pMHC-II	peptide loaded MHC-II
APC	antigen-presenting cell
Gal-3	galectin-3
LSECtin	liver sinusoidal endothelial cell lectin
FGL-1	fibrinogen like protein 1
IFN-γ	Interferon gamma
IL	Interleukin
Treg	regulatory T cell
NK	natural killer cell
pDC	plasmacytoid dendritic cell
DC	dendritic cell
TAM	tumor-associated macrophage
TOX	thymocyte selection-associated high mobility group box protein
NFAT	nuclear factor of activated T cells
NR4A	nuclear receptor subfamily 4, group A
TGF-β	transforming growth factor beta
EGR2	early growth response gene 2
ITIM	immunoreceptor tyrosine-based inhibitory motifs
LAP	LAG-3-associated protein
NSCLC	non-small-cell lung cancer
sLAG-3	soluble LAG-3
OS	overall survival
Zr89	Zirconium89
Fab	antigen binding fragment
scFv	single-chain variable fragment
TNF-α	tumor necrosis factor alpha